Log in or Sign up for Free to view tailored content for your specialty!
Lymphoma News
![FDA approves novel immunotherapy for cutaneous T-cell lymphoma](https://cdn.statically.io/img/www.healio.com/~/media/slack-news/generic-infographics/2023/generic-fda-news.jpg?w=400)
FDA approves novel immunotherapy for cutaneous T-cell lymphoma
The FDA approved the novel immunotherapy denileukin diftitox-cxdl for treatment of certain patients with relapsed or refractory cutaneous T-cell lymphoma.
European Medicines Agency recommends MabThera biosimilar for multiple indications
![European Medicines Agency recommends MabThera biosimilar for multiple indications](/~/media/slack-news/generic-infographics/2023/generic-industry-news.jpg?w=400)
The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the launch of proposed biosimilar rituximab candidate Ituxredi, Dr. Reddy’s Laboratories announced in a press release.
Findings highlight ‘critical importance’ of infectious complications after CAR-T
![Findings highlight ‘critical importance’ of infectious complications after CAR-T](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0724cordasdossantos_graphic_01.jpg?w=400)
Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
Iopofosine I 131 improves survival in Waldenström’s macroglobulinemia
![Iopofosine I 131 improves survival in Waldenström’s macroglobulinemia](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0724clover_graphic_01.jpg?w=400)
The investigational targeted radiotherapy iopofosine I 131 improved survival for certain patients with Waldenström’s macroglobulinemia, according to the agent’s manufacturer.
Shorter monitoring period after CAR-T may be possible, potentially expanding access
![Shorter monitoring period after CAR-T may be possible, potentially expanding access](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0724ahmed_graphic_01.jpg?w=400)
An FDA mandate that requires patients who receive chimeric antigen receptor T-cell therapy to stay within a certain radius of their treatment facility for nearly a month for adverse event monitoring may be overly restrictive.
Studies find benzoyl peroxide for acne has no increased risk for blood benzene, malignancy
![Studies find benzoyl peroxide for acne has no increased risk for blood benzene, malignancy](/~/media/slack-news/dermatology/misc/infographics/2024/07_july/derm0724sadr_graphic_01.jpg?w=400)
Patients with acne who used benzoyl peroxide products did not have a risk for malignancy or increased blood benzene levels, according to a pair of studies published in the Journal of the American Academy of Dermatology.
Women can have ‘successful and safe’ pregnancies after allogeneic transplant
![Women can have ‘successful and safe’ pregnancies after allogeneic transplant](/~/media/slack-news/stock-images/womens-health/pregnant-black-woman.jpg?w=400)
Women who undergo allogeneic hematopoietic cell transplantation can get pregnant and have healthy children, according to results of a retrospective study conducted in Germany.
HyBryte exhibits positive outcomes in early-stage cutaneous T-cell lymphoma
![HyBryte exhibits positive outcomes in early-stage cutaneous T-cell lymphoma](/~/media/slack-news/stock-images/hemonc/l/lymphoma-words_239833758.jpeg?w=400)
New interim results showed that HyBryte treatment demonstrated positive outcomes in patients with early-stage cutaneous T-cell lymphoma, according to a Soligenix press release.
FDA reduces risk reporting for CAR T cells to ‘minimize the burden’ on providers
![FDA reduces risk reporting for CAR T cells to ‘minimize the burden’ on providers](/~/media/slack-news/stock-images/hemonc/f/fdasign_323811316.jpg?w=400)
FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.
Physical exercise prevents nerve damage caused by chemotherapy
![Physical exercise prevents nerve damage caused by chemotherapy](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0624streckmann_ig14.jpg?w=400)
Certain physical exercises may prevent nerve damage caused by chemotherapy among individuals being treated for cancer, results of a randomized study published in JAMA Internal Medicine showed.
-
Headline News
FDA approves epinephrine nasal spray for anaphylaxis
August 09, 20242 min read -
Headline News
Third person dies in multistate Listeria outbreak linked to deli meats
August 09, 20241 min read -
Headline News
Women may face greater allergy, respiratory risks from household cleaning product use
August 09, 20246 min read
-
Headline News
FDA approves epinephrine nasal spray for anaphylaxis
August 09, 20242 min read -
Headline News
Third person dies in multistate Listeria outbreak linked to deli meats
August 09, 20241 min read -
Headline News
Women may face greater allergy, respiratory risks from household cleaning product use
August 09, 20246 min read